NLST — National Lung Screening Trial
The trial that established LDCT screening; its images plus outcomes trained Sybil and remain the only large public-by-application longitudinal LDCT cohort.
At a glance
Labels and annotations
Screening results, nodule findings, cancer diagnoses with histology and stage, and cause-specific mortality — outcome labels that make longitudinal risk modelling possible.
Details
Not yet documented on this card.
Models trained or evaluated on it
- training Sybil MIT Jameel Clinic / Massachusetts General Hospital — training and held-out test
Sources
This page is educational — it is not medical advice and does not replace consultation with an oncologist. Diagnostic and treatment decisions are made solely by specialist physicians.